Evonik

Evonik is one of the world’s leading specialty chemical companies. Our broad, versatile portfolio of functional excipients, technologies and CDMO services for oral and parenteral dosage forms makes us a global leader for advanced drug delivery. We also serve as a global CDMO for small molecule APIs, HPAPIs and intermediates, and supply high-quality, innovative cell culture solutions and amino acids. Evonik operates a trusted global network of manufacturing sites, laboratories and development centers around the world. We have a track record of providing enabling solutions to more than 1,000 pharmaceutical, med-tech and nutraceutical customers worldwide, including 90% of the world’s top life-science companies.

For more than 70 years, Evonik has been a preferred global supplier of functional excipients for oral solid dosage forms and complex parenterals. EUDRAGIT® is the world’s leading portfolio of polymethacrylate-based coating systems for the immediate, delayed or sustained release and solubility enhancement of oral solid dosage forms. The new EUDRACAP® platform of functional ready-to-fill capsules provides best-in-class functional performance and custom versatility for optimized release profiles and accelerated speed-to-market. With EUDRATEC® we have established an extensive portfolio of patent-protected and commercially feasible oral drug delivery technologies to overcome complex formulation challenges.

As one of the world’s leading CDMOs for complex parenteral drug products, our portfolio includes the market leading RESOMER® & LACTEL® portfolio of bioresorbable excipients, as well as CMO services for proprietary excipients. Evonik also offers lipids for injectable lipid nanoparticle (LNP) formulations including PhytoChol® vegetal-derived cholesterol & capabilities for custom manufactured lipids. CDMO services include the formulation & process development, GMP manufacturing & aseptic filling of drug products that utilize polymeric or lipid-based delivery technologies